patient experience
Doc Sinclair
Family, music, rocks, fish — Doc Sinclair is a man of many passions. As he faces brain cancer, he strives to maintain an active, full life.
Janice Armbrust
Decades of hiking and rock climbing taught Janice Armbrust how to handle the greatest uphill battle of her life: one day — one step — at a time.
Joël Bernier
For Joël Bernier, music has always been a source of joy and purpose. He rediscovered its power following a glioblastoma diagnosis.
Mike Hugo
Mike Hugo has packed a lot of life in his years, and he wants to teach his daughters to live with the same vigor and resolve.
Linda Long
Linda Long always saw the road ahead as she pursued her dream, making history in the Philadelphia Fire Department. Then she was diagnosed with glioblastoma.
Jovan Knutson
A glioblastoma diagnosis led Jovan Knutson to reevaluate what is most important to her. She has found joy in the moment, and with it, a renewed sense of purpose and resilience.
D.J. Stewart
D.J. Stewart has a few choice words for glioblastoma, which he’s faced with defiant optimism. Now he’s joining the larger rebellion against brain cancer.
Bruce Stahlman
Bruce and Kelly Stahlman found strength in gratitude as they raised, and then lost, twin boys with disabilities. They have faced Bruce’s glioblastoma with the same relentless spirit.
our culture
enabling smooth starts
Starting work in a new company can be challenge. At Novocure, our team of dedicated HR Specialists work diligently so that new employees have what they need for smooth starts.
‘helping patients is what keeps me motivated’
Empathy is one of Syed Ali’s greatest strengths. He uses the skill as Manager of the Financial Coordinators, a patient-facing team.
making a difference as a business analyst
Ana Sofia Pinheiro Nunes helps her colleagues improve their processes. She learned from her late mother that when facing challenges, courage makes all the difference.
the foundation of trust
DeEtta Ard-McDonald, a Senior Territory Manager in South Chicago, draws on her long marriage as an example of unwavering trust that has shaped her life and led to her career at Novocure.
supporting patients in Israel
As our the first contact from Novocure for patients in Israel, Karen Huller aims to empathize and make a trusted connection.
reinventing our first contact with patients
When his best friend was diagnosed with cancer, Nicholas Doucette decided to dedicate his professional life to helping cancer patients.
why innovation takes courage
Joachim believes that at the heart of every innovation is courage. He communicates the stories of his colleagues to encourage others.
supporting investigators in TTFields clinical trials
As many physicians are using TTFields therapy for the first time to treat their patients in clinical trials, Jonathan Gephart educates them on the science and administration of TTFields therapy.
features
Novocure joins New Hampshire Life Sciences
We will work with industry partners to champion New Hampshire’s cutting-edge life sciences sector and improve patients’ lives.
extra in the ordinary
Share stories of finding purpose and joy in simple moments while living with GBM.
you are not alone in facing a cancer diagnosis
Lean on patient advocacy groups for the support you need.
a Q&A with our founder
Novocure founder Professor Yoram Palti, recipient of the 2022 Israel Prize for excellence in entrepreneurship and technological innovation, reflects on his discovery of Tumor Treating Fields.
Novocure pledges $250K to Families First Health and Support Center
We committed the lead corporate gift to the capital campaign for a New Hampshire community health center’s new home.
lighting the world blue
Mesothelioma Awareness Day takes place annually in the U.S. on Sept. 26.
standing with the brain tumor community
As a global oncology company focusing on improving survival in some of the most aggressive forms of cancer, Novocure proudly stands with the brain tumor community during May for Brain Tumor Awareness Month (BTAM).
Ignace Vergote, Novocure Clinical Trial Investigator
Professor Ignace Vergote has dedicated his 32-year career to investigating treatment options and striving to improve survival in gynecologic cancers. Among gynecologic cancers, ovarian cancer is the deadliest, representing the fifth most common cause of cancer death among women in the United States. Five-year survival in ovarian cancer has slowly increased from 34 percent in 1975 to 47 percent today.
